G Soma
Overview
Explore the profile of G Soma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin Q, Ototake M, Noguchi K, Soma G, Yokomizo Y, Nakanishi T
Fish Shellfish Immunol
. 2001 Jun;
11(3):245-56.
PMID: 11394691
The presence of a Tumor Necrosis Factor alpha (TNFalpha)-like molecule has been suggested in fish by biological assays and biological and antigenic cross-reactivities with human TNFalpha. In the present study,...
2.
Inagawa H, Kuroda A, Nishizawa T, Honda T, Ototake M, Yokomizo U, et al.
Fish Shellfish Immunol
. 2001 Jun;
11(3):217-31.
PMID: 11394689
Fish beta-galactoside binding lectin (galectin) cDNA was cloned from the cDNA library of rainbow trout (Oncorhynchus mykiss) head kidney. The clone contained a single open reading frame encoding 341 amino...
3.
Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, Soma G, et al.
Neurol Med Chir (Tokyo)
. 2001 May;
41(4):187-95.
PMID: 11381677
Tumor necrosis factor receptor type 1 (TNFR1) and c-Myc are important in signal transduction in tumor necrosis factor-alpha (TNF-alpha)-induced cytotoxicity, whereas activation of nuclear factor-kappa B (NF-kappa B) protects against...
4.
Nakamoto T, Inagawa H, Takagi K, Soma G
Anticancer Res
. 2000 Dec;
20(6A):4087-96.
PMID: 11131677
There are primary and secondary malignant liver tumors for which principal treatment is surgical resection. There is no established treatment for unresectable malignant liver tumors, however, and the prognosis for...
5.
Yamamoto M, Fukushima T, Ueno Y, Hayashi S, Kimura H, Soma G, et al.
Anticancer Res
. 2000 Dec;
20(6A):4081-6.
PMID: 11131676
Background: The application of human mutant recombinant TNF-alpha (TNF-SAM2) to glioblastoma has shown that there is marked variation in its sensitivity to TNF. To determine whether the production of endothelial-monocyte...
6.
de Wilt J, Soma G, Ten Hagen T, Kanou J, Takagi K, Nooijen P, et al.
Anticancer Res
. 2000 Dec;
20(5B):3491-6.
PMID: 11131652
An isolated limb perfusion model (ILP) using soft tissue sarcoma bearing rats (BN175) was used to study antitumour activity of a tumour necrosis factor alpha mutant (TNF-SAM2) in combination with...
7.
Yoshimura H, Chikamoto A, Honda T, Tashiro K, Nakamoto T, Takano M, et al.
Anticancer Res
. 2000 Apr;
20(1C):629-33.
PMID: 10769707
Background: Although we have reported that the inducibility of endogenous tumor necrosis factor (en-TNF) by tumor cells is an independent prognostic factor in Dukes stage C colorectal cancer patients, the...
8.
Nakamoto T, Inagawa H, Takagi K, Tashiro K, Yoshimura H, Nishizawa T, et al.
Anticancer Res
. 2000 Apr;
20(1C):623-8.
PMID: 10769706
Background: The application of an isolation procedure with tumor necrosis factor (TNF) to the liver is quit attractive, however, one of problems to overcome is reducing the toxicity to the...
9.
Nakamoto T, Inagawa H, Takagi K, Tashiro K, Yoshimura H, Nishizawa T, et al.
Anticancer Res
. 2000 Apr;
20(1C):619-22.
PMID: 10769705
Background: Although the application of an isolation procedure with tumor necrosis factor (TNF) to the liver is quite attractive, an animal model is not yet available to evaluate antitumor effects...
10.
Yamamoto M, Fukushima T, Hayashi S, Ikeda K, Tsugu H, Kimura H, et al.
Anticancer Res
. 2000 Apr;
20(1C):611-8.
PMID: 10769704
We present our experience with a combination chemotherapy regimen consisting of ranimustine (MCNU) and recombinant human mutant tumor necrosis factor-alpha (TNF-SAM2) for malignant astrocytomas. We also investigated the expression of...